- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07411807
Study of the Effectiveness of a Systematic Minimal Early Intervention on Care Engagement in Adults With Eating Disorders Requesting Specialized Treatment. (AGIS-TCA)
Study of the Effectiveness of a Systematic Minimal Early Intervention on Care Engagement in Adults With Eating Disorders Requesting Specialized Treatment: A Monocentric Pilot Study.
Eating disorders (EDs) are complex psychiatric conditions-such as anorexia nervosa and bulimia nervosa-often emerging in young adulthood and associated with high morbidity and mortality. Despite their severity, access to specialized care remains difficult, delayed by shame, stigma, and a lack of insight among patients, as well as long waiting times and limited specialized resources.
The AGIS-TCA pilot study aims to evaluate the effectiveness of a systematic minimal early intervention designed to reduce the number of patients lost to follow-up between their request for specialized care and the actual start of treatment.
This monocentric, low-risk interventional study will be conducted at the Clinique des Maladies Mentales et de l'Encéphale (CMME), GHU Paris Psychiatrie & Neurosciences. The intervention includes three early, structured telephone calls and five online support group sessions offered during the waiting period for care.
The main objective is to determine whether this proactive approach decreases attrition rates ("lost to follow-up") compared with a historical cohort. Secondary objectives include assessing the acceptability of early phone contact, adherence to support groups, and describing the clinical and sociodemographic profiles of patients requesting care or lost to follow-up.
The expected benefit is to facilitate timely access to care for vulnerable patients, prevent symptom worsening, and strengthen engagement in treatment pathways. Risks and constraints are minimal, as participation involves only remote interactions without any invasive procedures.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Eating disorders (EDs) such as anorexia nervosa and bulimia nervosa are severe psychiatric illnesses characterized by pathological eating behaviors and body-weight control strategies that significantly affect physical and mental health. These disorders typically emerge around age 18 and affect up to 2 million people in France. Despite the recognized importance of early treatment, many patients experience delays in accessing specialized care due to structural barriers (long waiting times, lack of resources) and individual factors (shame, denial, and poor insight into the illness).
At the Clinique des Maladies Mentales et de l'Encéphale (CMME), GHU Paris Psychiatrie & Neurosciences, approximately 20-25% of patients who request specialized care for an eating disorder are lost to follow-up before starting treatment. These individuals often fail to complete their application or do not attend the initial evaluation. The AGIS-TCA (Action Globale d'Intervention Systématique - Troubles du Comportement Alimentaire) study addresses this critical period between the request for care and the beginning of treatment.
The study tests the effectiveness and acceptability of a minimal, systematic, early intervention that supports patients during this waiting phase. The intervention consists of:
Three structured telephone calls (AT1, AT2, AT3) conducted at approximately day 7, day 45, and day 90 after the validation of the care request. These calls aim to maintain contact, provide information, assess needs, and strengthen motivation.
Five online support and education group sessions, each lasting 60 minutes and held biweekly, led by a multidisciplinary team (specialized nurse, physician, dietitian, psychologist, psychomotor therapist, and peer support worker). Topics include medical aspects of EDs, body image, emotions, dietetics, and relationships with relatives.
This proactive "outreach" approach is compared to a historical control cohort from the previous year, managed under standard procedures (no systematic follow-up during the waiting period).
The primary endpoint is the rate of patients lost to follow-up (patients who requested care but did not attend evaluation or start treatment within 10 months).
Secondary endpoints include:
Participation rate in support groups.
Acceptance rate of early telephone contact.
Sociodemographic and clinical characterization of patients requesting care and those lost to follow-up.
The study is monocentric, non-randomized, and involves minimal risk. It includes 215 adult participants living in the Île-de-France region who have requested care for anorexia or bulimia at the CMME.
Expected benefits include improved engagement in care, reduced loss to follow-up, and earlier access to specialized treatment. The intervention is non-invasive, free of physical constraints, and participation or withdrawal has no impact on future access to care.
If effective and acceptable, the results of this pilot study could support the implementation of similar early intervention programs across other specialized eating disorder centers and form the basis for a multicenter study assessing long-term clinical outcomes and cost-effectiveness.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: OUIZA Mme MANSEUR, PROJECT MANAGER
- Phone Number: +33 1 45 65 84 01.45.65.61.65
- Email: ouiza.manseur@ghu-paris.fr
Study Locations
-
-
-
Paris, France, 75014
- Recruiting
- GHU Paris Psychiatrie et Neurosciences
-
Contact:
- Philibert DURIEZ, MD, PhD
- Phone Number: +3345658345
- Email: p.duriez@ghu-paris.fr
-
Contact:
- Marion DELOULAY
- Phone Number: 01 45 65 83 43
- Email: m.deloulay@ghu-paris.fr
-
Principal Investigator:
- Marion DELOULAY, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Individual who has submitted a request for care to the CMME for an eating disorder (anorexia nervosa or bulimia)
- Adult (18 years or older) Resident of the Île-de-France region
Exclusion Criteria:
- Body mass index (BMI) greater than 30 kg/m²: these patients will be directed, from the first telephone contact, to structures or care networks that can offer appropriate treatment.
Poor understanding of the French language
Sensory impairment significantly affecting telephone communication
Patient currently receiving care at a specialized eating disorder facility at the time of the call
Patient not consenting to participate in the study
Subject under legal protection measures (guardianship or curatorship)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: AGIS-TCA Intervention Group
Participants will receive a systematic minimal early intervention designed to maintain engagement during the waiting period before specialized treatment for an eating disorder. The intervention includes: Three structured telephone calls (AT1, AT2, AT3) at approximately day 7, day 45, and day 90 after validation of the care request. These calls aim to provide information, emotional support, and risk prevention guidance, and to maintain motivation for treatment. Five online support group sessions (60 minutes each, every two weeks) led by a multidisciplinary team (specialized nurse, physician, dietitian, psychologist, psychomotor therapist, and peer support worker). Duration: 3 months per participant. Number of Participants: 215 adults. Study Site: Clinique des Maladies Mentales et de l'Encéphale (CMME), GHU Paris Psychiatrie & Neurosciences. |
The AGIS-TCA intervention consists of a structured early proactive support program designed to maintain patient engagement during the waiting period before specialized treatment for eating disorders
|
|
No Intervention: Historical Comparison Group
A historical cohort of patients who requested specialized care for an eating disorder during the previous year (01/11/2024-31/10/2025), before implementation of the AGIS-TCA program. These patients received standard care procedures, which involved no systematic contact during the waiting period between their request for treatment and the start of care. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Patients Lost to Follow-Up
Time Frame: 7 months
|
The primary outcome is the difference in the rate of patients lost to follow-up between the intervention group (AGIS-TCA program) and a historical control cohort. A patient is considered lost to follow-up if they have submitted a valid request for specialized care (excluding cases of reorientation) but have not attended the evaluation days at the Eating Disorders Expert Center (CMME) or completed their intake process within 10 months of their initial request. |
7 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to Online Support Groups
Time Frame: At the end of the 3-month
|
Adherence will be measured by comparing the number of participants offered the support group sessions with the number of participants who attend at least one 60-minute online session.
This indicator reflects engagement and feasibility of the AGIS-TCA program's group component.
|
At the end of the 3-month
|
|
Acceptability of Early Telephone Contact
Time Frame: first 7 days
|
Acceptability will be measured by the proportion of eligible patients successfully reached during the first telephone contact (AT1) compared with the total number of patients invited.
It evaluates the practicality and acceptance of proactive outreach by patients awaiting care.
|
first 7 days
|
|
Clinical and Sociodemographic Profile of Patients Requesting Specialized Care
Time Frame: the 6-month
|
Characterization of all patients requesting specialized care for eating disorders, based on collected data: age, sex, socioeconomic background, presumed diagnosis, and illness duration.
This will provide a descriptive overview of the population accessing the service.
|
the 6-month
|
|
Clinical and Sociodemographic Profile of Patients Lost to Follow-Up
Time Frame: end of the 10-month
|
Characterization of patients identified as lost to follow-up, using the same variables (age, sex, socioeconomic background, presumed diagnosis, illness duration) to identify potential predictors of disengagement from care.
|
end of the 10-month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: MARION Mme DELOULAY, Nurse, Hôpital Sainte-Anne
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- D24-P028
- 2025-A00104-45 (Registry Identifier: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eating Disorders
-
Ibn Haldun UniversityActive, not recruitingDisordered Eating Behaviors | Eating Pathology | Eating Disorder SymptomsTurkey
-
Ibn Haldun UniversityCompletedDisordered Eating Behaviors | Eating Pathology | Eating Disorders SymptomsTurkey
-
Axsome Therapeutics, Inc.Enrolling by invitationBinge-Eating DisorderUnited States
-
BioprojetCompleted
-
Ali RezaiActive, not recruiting
-
University of PalermoUniversity of Padova; University of CatanzaroRecruitingEating Disorders | Eating Behavior | Eating Disorder SymptomItaly
-
Axsome Therapeutics, Inc.RecruitingBinge-Eating DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBinge-Eating DisorderUnited States
-
Mclean HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedBinge-Eating DisorderUnited States
-
University of North Carolina, Chapel HillThe Hilda & Preston Davis Foundation; Global Foundation for Eating DisordersCompletedEating Disorder | Binge-eating DisorderUnited States
Clinical Trials on Program (Systematic Minimal Early Intervention for Eating Disorders)
-
University of MichiganCompletedAnorexia Nervosa | Bulimia NervosaUnited States
-
Tel Hai CollegeCompletedFeeding and Eating DisordersIsrael
-
Aaron KeshenQueen Elizabeth II Health Sciences Centre FoundationRecruitingDisordered Eating Behaviors | Bariatric Surgery PatientsCanada
-
Al Hayah University In CairoRecruitingDistal Radius FracturesEgypt
-
Drexel UniversityNational Institute of Mental Health (NIMH)RecruitingBinge-Eating Disorder | Bulimia | Bulimia Nervosa | Binge EatingUnited States
-
Medipol UniversityIstanbul Medipol University HospitalActive, not recruitingDevelopmental Delay | Spinal Muscular AtrophyTurkey (Türkiye)
-
The Miriam HospitalCompleted
-
Federal University of BahiaCompletedThe INFLUENCE of PHYSICAL ACTIVITY on the HEALTH and WELL-BEING of BREAST CANCER SURVIVORS (PAF-SBM)Breast Cancer SurvivorBrazil
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedWeight Loss | Cardiovascular Risk Factor | Diet, HealthyUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruitingBreast CarcinomaUnited States